Daily Mail Online Mail+
1.2m+ most covid vulnerable-immunocompromised-shielded in 2020 are STILL WAITING FOR COVID PROTECTION!
Vaccines don’t work 4 us

25% all deaths-just 2% of Popn

Uk only leading 🌍 NOT to give Evusheld & it’s happening again

Pls report!!
Forgotten Lives Uk

UK Health Security Agency We know 1.2 million + immunocompromised who get zero vaccine protection are struggling to live

Year 5 STILL SHIELDING IS CALLOUS

2% of Popn = 25-28% all covid ICU & deaths!

Get some interim results & order Evusheld 2 like France

life is impossible for us 💔

Forgotten Lives Uk

Clinically Vulnerable Families 💙💜💗 AstraZeneca Evusheld for the UK NICE NHS England Fighting For Vulnerable Lives Forgotten Lives Uk Immunodeficiency UK Independent SAGE Seema Malhotra MP💙 The Vulnerable and Shielding Network

Dr Lennard Lee (Oxford University) Forgotten Lives Uk I'm on the supernova trial & don't know what I had but it has given me more freedom, still the only 1 wearing a mask & told I don't have 2
It would be great if NICE Department of Health and Social Care the uk supported Victoria Atkins Rishi Sunak how about some pressure Keir Starmer Bill Esterson

Please 🙏 NICE 🙏Victoria Atkins Rishi Sunak
Don’t make us wait for SIPAVIBART in U.K. till no longer effective like you did with Evusheld - so cruel when given free in USA and many other countries. We deserve better after waiting 4 years.
Forgotten Lives Uk

1/x *** New Research ***. 😀What can be done to protect immunocompromised patients? New press release from AstraZeneca. astrazeneca.com/media-centre/p…, and it's about a therapy called Sipavibart, the successor to Evusheld.

2/x. What is the background? Some individuals in our community are more prone to infections, they are called immunocomromised. There are ~ 500,000-1.5M with these conditions. When they get infections, they can fight it less well. 🙄 And the pandemic hit, this was a problem.

3/x It includes renal transplant patients, primary immunodeficiencies, those with cancer & blood cancers, kidney disease, and those with primary immunodeficiencies. It's a fair number. Most doctors want to protect these patients from infectious diseases by what ever means 😇

4/x In 2021, for those that didn't get enough protection from their COVID-19 vaccines, most countries gave additional protection to those patients, by an antibody, called Evusheld. It helped over that winter and reduced severity of infectious for many many people. 👍

5/x Whilst most companies stopped developing protective drugs. One manufacturer kept going, and they did all the trials required. The trial in immunocompromised patients was called SUPERNOVA.

6/x Run at 197 trials, the updated drug, called SIPAVIBART is reported to have 'statistically significant reduction in the incidence of symptomatic COVID‑19 compared to control'

7/x The data is just a press release, and not all numbers are available. However, my expert US friend Prof Haidar, Ghady Haidar MD notes 'sipavibart has the potential to provide much-needed protection against COVID-19 in this highly vulnerable population.”

8/x What do I think? I'd like to see more data.... however, I am cautiously positive. For vulnerable patients wishing to access new therapies to boost their immune defences against COVID-19, this could be it.

9/x. The challenge is whether patients in the UK will be able to get it in 2024, or should we be planning for for some time in 2030 again? 😇 Some countries always have their patients at the front of the line for protective therapies. 😝

10/x. If you were in the UK and interested, do talk to your patient charities. And if you're in the UK, you can find out more from Forgotten Lives Uk .

11/x. Sorry for the gap, with the X rebrand, I had reduced faith in twitter, though this was something I wanted to tweet about. Do tell me how you are feeling about this info.

We just wanted to share with you the information below, which is a chance to have your say on the call for evidence on the Fit Note Reform relating to disabled people. gov.uk/government/cal…

Free and open to all! Come along to our webinar for an update on @STRAVINSKYStudy’s progress so far.

✅Hear the latest on #COVID19 immunity in clinically vulnerable people
✅See how you could get involved

⏲️18:00-19:00, Weds 24 April
🔗immunology.org/events/update-…

Professor Alex Richter

Next, after +++outreach and public engagement around how to manage mental health at home while #shielding , I teamed up with Luca Bernardi Forgotten Lives Uk & APPG on Vulnerable Groups to Pandemics to produce an important, policymaker facing report with key recommendations for this group

tinyurl.com/2wth549h

One of the key findings was that those who were shielding others were experiencing 'vicarious' health anxiety, excessive worry about the vulnerable person they were #shielding . We recommended adapted evidence-based interventions. See below for more 👇

theconversation.com/many-people-ar…